KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

Kidney international 2024 Jan

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

Related Questions

How do you approach discussing the pill burden of voclosporin with patients who already have to take a regimen such as MMF+HCQ+ACEi and possibly more?

New answer by at NYU Langone Health (May 23, 2024)

Medication adherence and a chronic disease such as lupus is an issue regardless of the number of medications. For example, hydroxychloroquine is very effective, but studies of...

Read more (2 Answers available)

What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?

How do the 2024 ACR Lupus Nephritis Guidelines impact your timeline for taper?

New comment by at University of Nevada - Las Vegas ( August 29, 2025)

Thanks for highlighting this paper. Have looked repeatedly over the past two decades, updating an UpToDate card on immunologic effects of glucocorticoids and ZERO data for us...

Read more (6 Answers available)

Would you proceed with renal transplant in a patient with lupus nephritis who has progressed to ESRD and is clinically stable, but has persistently elevated dsDNA and low complements despite appropriate doses of hydroxychloroquine and mycophenolate?

New comment by at Hospital Perea ( August 28, 2025)

Agree with Dr. @Adey. Quiescence is the magic word.

Read more (4 Answers available)

Are there instances when you consider rituximab first line in a patient with class V LN?

Do you only reserve this for refractory cases?

New answer by at UT Southwestern Medical Center (September 2, 2025)

I do not use rituximab for first-line therapy for class V disease. I would consider it in refractory cases.

Read more (2 Answers available)